Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

BrainsWay Ltd.

BWAYNASDAQ
Healthcare
Medical - Devices
$13.71
$-0.03(-0.22%)
U.S. Market opens in 10h 13m

BrainsWay Ltd. (BWAY) Stock Overview

Explore BrainsWay Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap537.7M
P/E Ratio32.77
EPS (TTM)$0.16
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$23.28
3 Months$26.73
1 Year Target$28.87

BWAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BrainsWay Ltd. (BWAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 32.23, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $28.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.77 and a market capitalization of 537.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.22%
5-Day Change
7.45%
1-Month Change
19.22%
3-Month Change
61.48%
6-Month Change
73.76%
Year-to-Date (YTD) Change
42.07%
1-Year Change
168.30%
3-Year Change
1316.98%
5-Year Change
213.01%
All-Time (Max) Change
147.03%

Contact Information

972 2 582 4030
Bynet Building, Jerusalem, NaN, 9777518

Company Facts

1,200 Employees
IPO DateApr 17, 2019
CountryIL
Actively Trading

Frequently Asked Questions